Alter, Idris Joint Study Shows Engineered Antibodies Improve Malaria Protection
Apr 24, 2025 Features
A recent study published in Science Translational Medicine, co-authored by Ragon Institute faculty members Azza Idris, MD, PhD, and Galit Alter, PhD, demonstrates that engineering antibodies to enhance Fc receptor binding can significantly improve their effectiveness against malaria infection. The researchers tested modified versions of human monoclonal antibodies, CIS43LS and L9LS, which target a protein […]